Skip to content

Clinical trials

Overweight trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Belgium Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20111
20151
20162
20171
20183
20192
20201
20225
20234
20242
20258
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22
Completed15
Unknown status4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Universitaire Ziekenhuizen KU Leuven6
Novo Nordisk A/S5
University Hospital, Ghent3
Amgen2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Vrije Universiteit Brussel2
Boehringer Ingelheim1
Erasme University Hospital1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight43
Obesity38
Atherosclerosis2
Body Weight2
Diabetes Mellitus2
Metabolic Diseases2
Nutrition Disorders2
Pediatric Obesity2
Sleep Apnea, Obstructive2
Agnosia1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.